Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Roundabout homolog 4 receptor is a transmembrane protein encoded by the ROBO4 gene in humans. It acts as a receptor for Slit proteins—at least for SLIT2—and plays a critical role in angiogenesis and vascular patterning, processes essential for the development and maintenance of the circulatory system. ROBO4 is primarily expressed in endothelial cells, where it contributes to the establishment of the endothelial barrier. It has been shown to suppress glioma-induced endothelial cell proliferation, migration, and tube formation by inhibiting VEGFR2-mediated activation of PI3K/AKT and FAK signaling pathways. The molecule is also known as "Magic roundabout" due to its unique role in vascular biology. Its involvement in pathological angiogenesis links it to diseases such as cancer, particularly those involving abnormal blood vessel growth or function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Roundabout homolog 4 receptor (ROBO4).